Expression of p53 protein in melanoma progression

Journal of Dermatological Science

Volumn 12, Issue 2, 1996, Pages 97-103

  Kanoko, Mpu ^a   Ueda, Masato ^a   Nagano, Tohru ^a   Ichihashi, Masamitsu ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Melanoma; p53 Protein; Tumor progression

Indexed keywords

PROTEIN P53;

ARTICLE; DNA DAMAGE; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; LYMPH NODE METASTASIS; MELANOMA; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SOMATIC MUTATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0029898968     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-1811(95)00465-3     Document Type: Article

References (35)

1. Bishop JM: Molecular themes in oncogenesis. Cell 64: 235-248, 1991.
2. Nigro JM, Baker SJ, Preisinger AC, et al.: Mutations in the p53 gene occur in diverse human tumour types. Nature (Lond.) 342: 705-708, 1989.
3. EI-Deiry WS, Tokino T, Velculescue VE, et al.: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825 1993.
4. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
5. Lu X, Lane DP: Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75: 765-778 1993.
6. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.) 362: 847-849, 1993.
7. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T Tisty T: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935 1992.
8. Carder P, Wyllie AH, Purdie CA, et al.: Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 8: 1397-1401, 1993.
9. Clark WH Jr, Elder DE, Guerry IVD, Epstein MN, Green MH, van Horn M: A study of tumor progression. The precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15: 1147-1165, 1984.
10. Lever WF, Schaumburg-Lever G: Benign melanocytic tumors and malignant melanoma, in Histopathology of the skin. 7th ed. Philadelphia, PA: J.B. Lippincott, 1990, pp. 756-805.
11. Van't Veer LJ, Burgering BMT, Versteeg R, et al.: N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol 9; 3114-3116, 1989.
12. Wagner SN, Ockenfels HM, Wagner C, Höfler H, Goos M: Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma. J Invest Dermatol 104; 868-871 1995.
13. Ueda M, Funasaka Y, Ichihashi M, Mishima Y: Stable and strong expression of basic fibroblast growth factor in naevus cell naevus contrasts with aberrant expression in melanoma. Br J Dermatol 130: 320-324, 1994.
14. Kamb A, Gruis NA, Weaver-Feldhaus J, et al.: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440, 1994.
15. Ohta M, Nagai H, Shimizu M, et al.: Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK41, in melanoma. Cancer Res 54: 5269-5272 1994.
16. Stretch JR, Gatter KC, Elisabeth R, Lane DP, Harris AL: Expression of mutant p53 in melanoma. Cancer Res 51: 5976-5979, 1991.
17. Bartek J, Bartkova J, Vojtesek B, et al.: Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6: 1699-1703, 1991.
18. Akslen LA, Mørkve O: Expression of p53 protein in cutaneous melanoma. Int J Cancer 52: 13-16, 1992.
19. Ro YS, Cooper PN, Lee JA, et al.: p53 protein expression in benign and malignant skin tumours. Br J Dermatol 128: 237-241, 1993.
20. Lassam NJ, From L, Kahn HJ: Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res 53: 2235-2238, 1993.
21. McGregor LM, Yu CC-W, Dublin EA, Barnes DB, Levison DA, MacDonald DM: p53 immunoreactivity in human malignant melanoma and dysplastic naevi. Br J Dermatol 128: 606-611 1993.
22. Yamamoto M, Takahashi H: Immunohistochemical detection of the p53 oncoprotein in tumours of melanocytic origin. Virchows Archiv A Pathol Anat 422: 127-132, 1993.
23. Cristofolini M, Boi S, Girlando S, et al.: p53 Protein expression in nevi and melanomas. Arch Dermatol 129: 739-743 1993.
24. Volkenandt M, Schlegel U, Nanus DM, Albino AP: Mutational analysis of the human p53 gene in malignant melanoma. Pigm Cell Res 4; 35-40, 1991.
25. Albino AP, Vidal MJ, McNutt NS, et al.: Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 4: 35-45, 1994.
26. Flørenes VA, Øyjord T, Holm R, Skrede M Børresen A-L, Nesland JM, Fodstad Ø: TP53 allele loss mutations and expression in malignant melanoma. Br J Cancer 69: 253-259, 1994.
27. Lübbe J, Reichel M, Burg G, Kleihues P: Abscence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol 102: 819-821, 1994.
28. Yamamoto M, Takahashi H, Saitoh K, Horikoshi T Takahashi M: Expression of the p53 protein in malignant melanomas as a prognostic indicator. Arch Dermatol Res 287: 146-151, 1995.
29. Shi S-R, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues; an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
30. Elwood JM: Epidemiology and control of melanoma in white populations and in Japan. J Invest Dermatol 92: 2145-2215, 1989
31. Nagano T, Ueda M, Ichihashi M: Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Arch Dermatol 129: 1157-1161 1993.
32. Hall PA, McKee PH, Menage H du P, Dover R, Lane DP: High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8: 203-207, 1993.
33. Campbell C, Quinn AG, Angus B, Farr PM, Rees JL: Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation. Cancer Res 53: 2697-2699 1993.
34. Campbell C, Quinn AG, Angus B, Rees JL: The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. Br J Dermatol 129: 235-241, 1993.
35. Baas IO, Mulder JR, Offerhaus GJA, Vogelstein B Hamilton SR: An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172: 5-12, 1994.